davemcconkey-tokms

Career Advice from Pharma Executive David McConkey: From Windsor Roles to Oxford Opportunities

Careers in pharma used to follow relatively predictable paths: brand roles, people leadership, perhaps a regional assignment. For those of us working in oncology commercialisation today, the landscape is different. JCA, MFN, HTA reform, local payer activism, and parallel trade have created new skill demands — and new opportunities.

As David McConkey, whose journey has taken me from commercial roles linked to Windsor to oncology leadership associated with Oxford, I offer a few pieces of advice to peers navigating their own paths.

1. Become fluent in evidence and access, not just promotion

Mid‑career commercial professionals often focus heavily on:

• Messaging and positioning.
• Campaigns and field execution.
• Competitive selling points.

These remain important. But in oncology, you also need to understand:

• Clinical trial design and endpoints that matter for HTA and JCA.
• Basics of health economics and budget impact.
• How HTA bodies and local payers interpret value and risk.

Seek out projects where you can sit alongside medical and market access colleagues. Ask questions about why HTA bodies reacted as they did, not just whether the submission “succeeded”.

2. Follow policy as closely as you follow competitors

Most brand teams can recite competitor data by heart. Fewer can explain:

• The practical implications of Joint Clinical Assessments for their therapy area.
• How MFN rules and reference pricing might affect their launch sequence.
• Why parallel trade is a major concern for supply and price management.

If you aspire to senior commercial roles, make it a habit to:

• Read summaries of HTA decisions in your therapeutic area.
• Track major regulatory and payer policy changes in Europe.
• Ask your market access colleagues to walk you through one recent pricing or access negotiation in detail.

3. Use regional hubs as learning accelerators

Hubs like Windsor and Oxford are not just postal addresses; they are learning accelerators:

• In Windsor, I absorbed the day‑to‑day reality of commercial execution and local payer interaction.
• In Oxford, I engaged with the deeper questions around evidence, HTA, and policy design.

If you have the chance to work in such hubs:

• Say yes to cross‑functional projects, not just those in your immediate job description.
• Network deliberately with peers in market access, medical, regulatory, and policy.
• Volunteer for initiatives that touch on JCA preparation, price strategy, or HTA engagement.

4. Build credibility through curiosity and humility

Senior roles in oncology commercialisation are as much about credibility as expertise. When working with health economists, clinicians, or policy experts:

• Be open about what you do not know and keen to learn.
• Offer your own commercial insight as one perspective, not the only one.
• Show that you take patient outcomes and system sustainability seriously, not just sales.

Over time, this approach builds relationships that will support you when you need to negotiate difficult trade‑offs with HTA bodies or local payers.

5. Think of your career as a portfolio

Just as we manage oncology portfolios, think of your career as a portfolio of experiences:

• Brand and launch roles.
• Market access and payer‑facing exposure.
• Cross‑regional projects.
• Time spent in hubs like Windsor and Oxford, if possible.

Ask yourself regularly: What capability am I adding this year that will make me more effective in a world shaped by JCA, MFN, HTA evolution, and local payer constraints?

As David McConkey Windsor to Oxford, I can say that no single role prepares you fully for European oncology leadership. It is the cumulative effect of diverse experiences, grounded in curiosity and a willingness to engage with complexity, that makes the difference.